HRMY Harmony Biosciences Holdings PE ratio, current and historical analysis

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 87

The P/E ratio for Harmony Biosciences Holdings stock stands at 13.96 as of Jul 24, 2026. This takes into account the latest EPS of $2.53 and stock price of $35.32. An increase of 29% has been observed in the PE ratio compared to its average of 10.8 of the past four quarters.

HRMY PE ratio history

How has HRMY's PE ratio performed in the past

Over the last six years, the average PE ratio of Harmony Biosciences Holdings has been 24.69. The current 13.96 price-to-earnings ratio is 43% less than the historical average. Analyzing the last six years, HRMY's PE ratio reached its highest point in the Mar 2021 quarter at 103.25, with a price of $33.04 and an EPS of $0.32. The Sep 2025 quarter saw the lowest point at 8.53, with a price of $27.56 and an EPS of $3.23.

Today
13.96
Average
24.69
Median
14.78
Minimum
8.53
Maximum
103.25

Harmony Biosciences Holdings PE ratio by year

Maximum annual increase: 0.89% in 2025

Maximum annual decrease: -74.74% in 2022

Year PE ratio PE change Price EPS
2025 13.56 0.89% $37.42 $2.76
2024 13.44 -9.68% $34.41 $2.56
2023 14.88 -17.1% $32.3 $2.17
2022 17.95 -74.74% $55.1 $3.07
2021 71.07 N/A $42.64 $0.6
2020 N/A N/A $36.15 -$2.48
2019 N/A N/A N/A -$24.07
2018 N/A N/A N/A -$7.91

Harmony Biosciences Holdings PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2026 11.07 -18.36% $28.01 $2.53
Dec 2025 13.56 58.97% $37.42 $2.76
Sep 2025 8.53 -14.7% $27.56 $3.23
Jun 2025 10 -19.55% $31.6 $3.16
Mar 2025 12.43 -7.51% $33.19 $2.67
Dec 2024 13.44 -27.74% $34.41 $2.56
Sep 2024 18.6 22.05% $40 $2.15
Jun 2024 15.24 6.65% $30.17 $1.98
Mar 2024 14.29 -3.97% $33.58 $2.35
Dec 2023 14.88 14.46% $32.3 $2.17
Sep 2023 13 24.16% $32.77 $2.52
Jun 2023 10.47 2.25% $35.19 $3.36
Mar 2023 10.24 -42.95% $32.65 $3.19
Dec 2022 17.95 6.59% $55.1 $3.07
Sep 2022 16.84 -66.16% $44.29 $2.63

HRMY Price vs fair value

How does HRMY's price compare to its estimated fair value based on its growth

HRMY average PE ratio chart

What is the average PE ratio of HRMY for the past years

The current PE ratio of HRMY is higher than the 3-year average, but it is under its 5-year average.

3-year avg
13.19
5-year avg
21.07
10-year avg
N/A
15-year avg
N/A

PE comparison

With a price to earnings (P/E) of 13.96, HRMY stands lower than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 25.31, Harmony Biosciences Holdings's price to earnings (P/E) is 45% lower.

HRMY PE vs peers

What is HRMY's PE ratio compared to its peers
Stock name PE ratio Market cap
HRMY Harmony Biosciences Holdings Inc 13.96 $2.04B
OPK Opko Health Inc N/A $921.21M
ORGO Organogenesis Holdings Inc N/A $307.53M

Frequently asked questions

What is Harmony Biosciences Holdings's PE ratio?

As of Jul 24, 2026, HRMY stock has a price to earnings ratio of 13.96.

What is the 3-year average PE ratio for Harmony Biosciences Holdings (HRMY)?

The 3-year average PE ratio for HRMY stock is 13.19.

What is the 5-year average PE ratio for Harmony Biosciences Holdings (HRMY)?

The 5-year average PE ratio for HRMY stock is 21.07.

What is the highest PE ratio for HRMY?

Over the last six years, the quarterly PE ratio reached its highest level at 103.25 in the Mar 2021 quarter.

How does the current PE ratio for HRMY compare to its historical average?

HRMY's price to earnings ratio is currently 43% below its 6-year historical average.

How is HRMY's PE ratio calculated (Harmony Biosciences Holdings PE ratio formula)?

The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jul 24, 2026), Harmony Biosciences Holdings's share price is $35.32. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $2.53. Therefore, Harmony Biosciences Holdings's price to earnings ratio for today is 13.96. PE RATIO(13.96) = STOCK PRICE($35.32) / TTM EPS($2.53)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.